GlycoMimetics Inc (NASDAQ:GLYC) price on Friday, May 02, fall -0.46% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.26.
A look at the stock’s price movement, the close in the last trading session was $0.26, moving within a range at $0.2549 and $0.278. The beta value (5-Year monthly) was 1.736. Turning to its 52-week performance, $1.84 and $0.14 were the 52-week high and 52-week low respectively. Overall, GLYC moved 24.75% over the past month.
GlycoMimetics Inc’s market cap currently stands at around $16.87 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-12.
Turning to the stock’s technical picture we see that short term indicators suggest on average that GLYC is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 0 recommend GLYC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
GLYC’s current price about 16.45% and 7.54% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 59.97, while 7-day volatility ratio is 10.87% and 10.37% in the 30-day chart. Further, GlycoMimetics Inc (GLYC) has a beta value of 1.71, and an average true range (ATR) of 0.02.
If we refocus on GlycoMimetics Inc (NASDAQ:GLYC), historical trading data shows that trading volumes averaged 0.72 over the past 10 days and 1.44 million over the past 3 months. The company’s latest data on shares outstanding shows there are 64.48 million shares.
The 13.04% of GlycoMimetics Inc’s shares are in the hands of company insiders while institutional holders own 42.40% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.97 million on 2025-04-15, giving us a short ratio of 6.8. The data shows that as of 2025-04-15 short interest in GlycoMimetics Inc (GLYC) stood at 369.00000000000006 of shares outstanding, with shares short falling to 2.58 million registered in 2025-03-14. Current price change has pushed the stock 5.06% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GLYC stock continues to rise going into the next quarter.
